Calcium Stimulated Calcitonin Measurement: A Procedural Proposal

Abstract

Human calcitonin (hCT) is a tumor marker essential to the diagnosis and follow-up of medullary thyroid cancer (MTC). Current consensus recommends hCT measurement when initially evaluating thyroid nodules; if slightly elevated, a confirmatory stimulated calcitonin test is commonly performed, usually using pentagastrin. In recent years the supply of pentagastrin was not guaranteed with long periods of unavailability; the outlook for future availability is unknown. Therefore it is desirable for many institutions to establish a procedure for calcitonin stimulation using a stimulant with a secure supply; stimulation of calcitonin using calcium represents the easiest alternative.

Several schemes and dosages have been used in the past for calcium stimulated calcitonin measurement. In this paper we propose a procedure for calcium stimulated calcitonin measurement based on our experiences. Furthermore we will briefly point out the limitations of this method with regard to available data in literature.

Key words

calcitonin - pentagastrin - calcium stimulation - medullary thyroid carcinoma - procedure

• References

• 1 Dietlein M, Dressler J, Grünwald F et al. Leitlinie zur Schilddrüsendiagnostik. Deutsche Gesellschaft für Nuklearmedizin 2003;
• 2 Karges W, Dralle H, Raue F et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58
• 3 Owyang C, Heath III H, Sizemore GW et al. Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man. Am J Dig Dis 1978; 23: 1084-1088
• 4 Sizemore GW, Go VL. Stimulation tests for diagnosis of medullary thyroid carcinoma. Mayo Clin Proc 1975; 50: 53-56
• 5 Hennessy JF, Wells Jr SA, Ontjes DA et al. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1974; 39: 487-495
• 6 Hennessy JF, Gray TK, Cooper CW et al. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1973; 36: 200-203
• 7 Wells Jr SA, Cooper CW, Ontjes DA. Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma – an effect apparently not mediated by gastrin. Metabolism 1975; 24: 1215-1219
• 8 Doyle P, Duren C, Nerlich K et al. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 2009; 94: 2970-2974
• 9 Colombo C, Verga U, Mian C et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 2012; 97: 905-913
• 10 Kratzsch J, Petzold A, Raue F et al. Comparison of basal and stimulated calcitonin and procalcitonin using different commercially available assays in patients with and without medullary thyroid cancer. Clin Chem 2010; in Press
• 11 Colombo C, Verga U, Perrino M et al. High-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls: comparison of the efficacy and the tolerance. Abstract, ITC 2010 2010; 2040.
• 12 Machens A, Hoffmann F, Sekulla C et al. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 2009; 16: 1291-1298